Key facts
- It has raised $2.3B; the latest was Secondary Transaction - Private in Feb 2025.
- Notable investors include Tiger Global Management, KB Investment, Temasek Holdings, B Capital Group, OrbiMed — 47 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 47 names
- ·Watchlist + deal alerts for PharmEasy
- ·The full record, as it builds
Funding rounds
No funding rounds for PharmEasy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PharmEasy
Operator of an online drug delivery platform designed to improve the supply chain of pharmaceuticals by completely digitizing the process. The company's application sells medicines and healthcare products and aids in connecting with local pharmacy stores and diagnostic centers to fulfill extensive medical needs, enabling patients to receive healthcare services that are easily available, affordable, and accessible.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Mumbai, India
- Founded
- 2014
- Employees
- 3,939
- Website
- pharmeasy.in/
- Ownership
- Privately Held (backing)
PharmEasy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PharmEasy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PharmEasy in its N-PORT filings yet. We sweep new filings monthly.